Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04821635Not ApplicableWithdrawn

Effects of FES-Rowing in Neurological Disorders (FES-ROW)

Role: lead

NCT06230796Not ApplicableRecruiting

Effects of Functional Electrical Stimulation Assisted Cycling in Patients With Hemiparesis After Stroke

Role: lead

NCT06421753Not ApplicableCompleted

Efficiency of Spatially Distributed Sequential Stimulation (Sdss) for Functional Electrical Stimulation (FES) of Upper Motor Neuron Syndrome (UMR) Patients

Role: lead

All 3 trials loaded